Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:49 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors
NCT00915928 · Odense University Hospital · NA · terminated · last registry update 2020-08-19 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “No effect of the ACE inhibitor evaluated halfway in the study” | – | Registry record, Odense University Hospital |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ACE within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-07-28Phase 3 first posted: Sun Yat-sen University, Multiple cardiovascular drugs related to "Golden Triangle" (NCT04980716)
- 2021-07-07Phase 3 first posted: Second Affiliated Hospital, Zhejiang University, School of Medicine, Enalapril Folic Acid Tablets Combined With amlodipine + Enalapril Folic Acid Tablets Combined With hydrochlorothiazide (NCT04952051)
- 2021-06-03Phase 3 first posted: West China Hospital, Sacubitril-Valsartan + Enalapril (NCT04912167)
- 2021-05-06Also stopped (suspended): University of Cape Town, a drug against ACE (NCT03071653)
- 2021-04-21Phase 3 first posted: University of Sao Paulo General Hospital, Sacubitril / Valsartan Oral Tablet [Entresto] + Enalapril (NCT04853758)
- 2021-04-13Results posted on the registry: Northwell Health, New Medication: Enalapril, Isradipine, Propranolol (NCT01007994)
- 2021-02-08Results posted on the registry: Novartis Pharmaceuticals, sacubitril/valsartan + Enalapril (NCT03066804)
- 2021-01-26Results posted on the registry: Imperial College London, perindopril arginine + amlodipine 5mgs (NCT01118520)
- 2020-10-19Phase 3 first posted: Ottawa Heart Institute Research Corporation, Angiotensin converting enzyme inhibitor + Angiotensin II Receptor Blockers (NCT04591210)
- 2020-10-19Phase 3 first posted: Institut de Recherches Internationales Servier, Atorvastatin/Perindopril + Atorvastatin (NCT04591808)
- 2020-10-09Results posted on the registry: Novartis Pharmaceuticals, LCZ696 + Enalapril (NCT02768298)
- 2020-06-30Also stopped (suspended): National University of Ireland, Galway, Ireland, Thiazide or Thiazide-like diuretics + Calcium Channel Blockers (NCT04330300)
- 2020-04-14Phase 3 first posted: Tanta University, ACEIs + Conventional treatment (NCT04345406)
- 2020-03-19Results posted on the registry: Novartis Pharmaceuticals, LCZ696 (sacubitril/valsartan) + Enalapril (NCT02874794)
- 2019-10-01Results posted on the registry: VA Office of Research and Development, Enalapril + placebo (NCT01754909)
- 2019-09-24Results posted on the registry: Novartis Pharmaceuticals, sacubitril/valsartan (LCZ696) + Enalapril (NCT02554890)
- 2019-09-16Results posted on the registry: Novartis Pharmaceuticals, LCZ696 (Sacubitril/Valsartan) + Placebo of LCZ696 (Sacubitril/Valsartan) (NCT02900378)
- 2019-09-12Results posted on the registry: British Columbia Cancer Agency, Regorafenib + Perindopril (NCT02651415)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision